Lantern Pharma's LP-300 signals a significant advancement in the fight against non-small cell lung cancer (NSCLC), particularly in never-smokers—a group seeing elevated incidence rates, notably in East Asia. This promising therapeutic option stands out as NSCLC treatments often overlook the unique
How Is Tech Innovation Shaping Biopharma Production? The biopharmaceutical industry is experiencing profound change thanks to technological advancements. These innovations are not just fine-tuning existing methods; they're revolutionizing drug development and production. Advanced analytics and
In a decisive response to safeguard the stability of the financial system, the United States government has stepped forward with a bold assurance directed at customers of the recently collapsed Silicon Valley Bank (SVB). Officials have made a clear commitment that starting Monday, those affected
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has recently announced an ambitious new program, Project Call 7.1, to stimulate advancement in biopharmaceutical production and broaden workforce capabilities. With a funding pool of around $10 million, NIIMBL plans
The Imperative for High-Quality Control in Biomanufacturing In the ever-evolving landscape of biopharmaceutical manufacturing, the imperative for maintaining high-quality control measures is unarguable. With the introduction of complex biological materials into gene therapies and vaccine
At the recent BPI Europe 2024 conference, a landmark discussion led by Uwe Buecheler from Boehringer Ingelheim marked the dawn of a new chapter in biopharmaceuticals. Described as the 'third wave' of biologics, it signifies an era brimming with groundbreaking therapeutic innovations that stand to
